FDA

FDA Issues Final Clinical Research Guidance For Cannabis

Jan 24, 2023

Revive Therapeutics Signals Intention To Swap Clinical Trial Endpoints With The FDA

Aug 16, 2022

Introducing Tessellate: A Psychedelic Company Interested In ‘Fitting It Together’

Jul 28, 2022

Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of…

Jun 27, 2022

Mydecine CEO Josh Bartch on FDA News and Smoking Cessation Treatments

Jun 24, 2022

U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

Jun 17, 2022

Mydecine Provides Company Update; Welcomes New Board Member

Jun 9, 2022

Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human Trial of CYB003 for the Treatment of Major…

May 31, 2022

Revive Therapeutics Advances Inflammatory Liver Disorders Programs for Autoimmune Hepatitis and Liver Transplantation

May 31, 2022

Revive Therapeutics: Positive Comments From The FDA Regarding Primary Endpoint Change

May 26, 2022